We specialize in oncology and rare diseases, with extensive experience conducting clinical trials across phases I–IV and medical device studies. Our team has successfully managed studies in various other therapeutic areas, allowing us to bring diverse expertise to your project while maintaining our core focus on complex and specialized trials.

Paspigioni operates across 21 countries, with particular expertise in emerging markets. Our headquarters is located in London, UK, and our international network enables us to design recruitment strategies that leverage regional strengths and access diverse patient populations efficiently.

Patient recruitment is one of our core strengths. We develop innovative, tailored enrollment strategies that combine local market knowledge with proven methodologies. Our focus on emerging markets and strong relationships with clinical sites allow us to meet recruitment targets on time while maintaining the highest quality standards.

We provide comprehensive support for all clinical trial phases—from Phase I through Phase IV—as well as medical device studies. Whether you're conducting first-in-human studies or post-marketing surveillance, our team has the regulatory expertise and operational capabilities to guide your trial to success.

Founded by a medical doctor with a passion for patient outcomes, Paspigioni combines clinical insight with operational excellence. We prioritize quality, precision, and reliability while offering cost-effective solutions. Our membership in leading organizations like EUCROF, One Nucleus, OBN, and BioPartner reflects our commitment to industry standards and continuous improvement.

Getting started is simple. Contact us through our website or LinkedIn to discuss your trial needs. Our team will schedule a consultation to understand your study requirements, timeline, and budget. We'll then develop a customized proposal outlining our approach, deliverables, and how we can help bring your treatment to patients who need it.